enasidenib
servier,bms
['enasidenib', 'leukemia', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)']
congress | #ash22
amandeep salhotra, , reports post-hsct enasidenib maintenance to be well-tolerated in 15 patients with idh2m aml, with anemia the most common ae. outcomes were favorable; lfs was 100%, and cgvhd-free rfs almost 80%, at 12 and 24 months.
#leusm 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm